Pharmaceutical - Pharmaceutical, North America, Vaccines

Filter

1 to 25 of 39 results

Pfizer tasked with novel vaccine research by US government department

Pfizer tasked with novel vaccine research by US government department

12-12-2013

Pfizer, the world’s largest drugmaker by sales, has been awarded a nearly $7.7 million technology investment…

North AmericaPfizerPharmaceuticalResearchVaccines

Emergent BioSolutions to acquire Cangene for $222 million

12-12-2013

Taking a significant step to solidify its leadership position in the growing biodefense market, US vaccine…

CangeneEmergent BioSolutionsMergers & AcquisitionsNorth AmericaPharmaceuticalVaccines

US FDA clears GlaxoSmithKline’s H5N1 flu vaccine

26-11-2013

The US Food and Drug Administration has approved UK pharma giant GlaxoSmithKline’s pandemic Influenza…

GlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

Merck & Co’s investigational HPV vaccine shows broader efficacy than Gardasil

Merck & Co’s investigational HPV vaccine shows broader efficacy than Gardasil

04-11-2013

Merck & Co has revealed an overview of its clinical trial program for V503, its investigational nine-valent…

GardasilMerck & CoNorth AmericaPharmaceuticalResearchVaccines

Merck & Co expects to file BLA for HPV vaccine candidate V503 this year

Merck & Co expects to file BLA for HPV vaccine candidate V503 this year

25-10-2013

Merck & Co yesterday provided an overview of the clinical trial program for V503, the company’s investigational…

Merck & CoNorth AmericaPharmaceuticalRegulationResearchV503Vaccines

US NIH trials flu vaccines from Sanofi and Novartis

US NIH trials flu vaccines from Sanofi and Novartis

19-09-2013

The US National Institutes of Health has begun testing an H7N9 avian influenza vaccine candidate in humans.

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalSanofi PasteurVaccines

271 vaccines for cancer and infectious diseases being developed in USA

12-09-2013

The USA's biopharmaceutical companies are developing 271 vaccines to prevent and treat a variety of conditions,…

North AmericaPharmaceuticalResearchVaccines

GSK's Flulaval vaccine approved by US FDA

16-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has had its Flulaval quadrivalent intramuscular influenza…

FluarixFlulavalGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

US FDA approves shipment of quadrivalent flu vaccine to health care providers

06-08-2013

The US subsidiary of UK pharma giant GlaxoSmithKline (LSE: GSK) says it has received Food and Drug Administration…

Anti-viralsFluarixGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

FDA expands age indication for Menveo, quadrivalent meningococcal vaccine

02-08-2013

The US Food and Drug Administration late yesterday (August 1) approved Swiss drug major Novartis' (NOVN:…

MenveoNorth AmericaNovartisPharmaceuticalRegulationVaccines

Slow uptake of HPV vaccine in USA "risks health of next generation"

29-07-2013

US human papillomavirus (HPV) vaccination rates in girls aged 13-17 years failed to increase between…

CervarixGardasilGlaxoSmithKlineHealthcareMerck & CoNorth AmericaPharmaceuticalVaccines

Negative FDA news for AVEO's tivozanib and Dynavax' hep B vaccine

11-06-2013

US biotech firm AVEO Oncology (Nasdaq: AVEO) says that it has received a complete response letter from…

Anti-viralsAstellas PharmaAVEO OncologyBiotechnologyDynavax TechnologiesHeplisavNorth AmericaOncologyPharmaceuticalRegulationtivozanibVaccines

GlaxoSmithKline cleared for $91M flu vaccine plant in USA; Gets CRL on Q-Plan H5N1

27-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and The Texas A&M University System (TAMUS) say that the US…

GlaxoSmithKlineNorth AmericaPharmaceuticalProductionQ-Plan H5N1RegulationVaccines

FDA approves three Takeda diabetes drugs; expands use of Novartis' Gleevec and Pfizer's Prevnar 13

28-01-2013

In what was a busy news day for the US Food and Drug Administration, the agency on Friday approved three…

alogliptinDiabetesFuriex PharmaceuticalsGleevecKazanoLiovelNesinaNorth AmericaNovartisOncologyOseniPfizerPharmaceuticalPrevnarRegulationTakeda PharmaceuticalsVaccines

FDA approves Protein Sciences egg-free flu vaccine Flublok; and Octapharma's Octaplas

18-01-2013

The US Food and Drug Administration revealed it has approved privately-held US biotech firm Protein Sciences…

Anti-viralsBiotechnologyFlublokMergers & AcquisitionsNorth AmericaOctapharmaOctaplasPanblokPharmaceuticalProtein Sciences CorpRegulationVaccines

H1N1 pandemic fears to maintain lofty US flu vaccination levels, says GlobalData

08-01-2013

US demand for influenza vaccines will remain high in the coming decade, following a post-flu pandemic…

Anti-viralsGlobalMarkets & MarketingNorth AmericaPharmaceuticalVaccines

GlaxoSmithKline gains FDA approval of four-strain seasonal influenza vaccine

17-12-2012

The US Food and Drug Administration has approved UK pharma giant GlaxoSmithKline's (LSE: GSK) Fluarix…

FluarixGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

CREW files motion to quash Sanofi Pasteur subpoena

06-12-2012

Washington DC, USA-based non-profit legal watchdog group Citizens for Responsibility and Ethics (CREW)…

LegalMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

Health Canada approves Vertex' Kalydeco; and Sanofi Pasteur's Menactra

03-12-2012

Vertex Pharmaceuticals (Nasdaq: VRTX) says that Health Canada has approved Kalydeco (ivacaftor), the…

BiotechnologyKalydecoMenactraNorth AmericaPharmaceuticalRare diseasesRegulationSanofiSanofi PasteurVaccinesVertex

FDA approves Novartis' Flucelvax, first seasonal flu vaccine using cell culture technology

21-11-2012

The US Food and Drug Administration yesterday approved Swiss drug major Novartis' (NOVN: VX) Flucelvax,…

FlucelvaxNorth AmericaNovartisPharmaceuticalProductionRegulationVaccines

FDA advisory panel backs GlaxoSmithKline H5N1 influenza vaccine candidate

15-11-2012

The US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC)…

GlaxoSmithKlineNorth AmericaPharmaceuticalPumarixRegulationVaccines

News briefs: Italy lifts hold on Novartis vaccines; files for QVA149 in Japan; Mylan patent settlement

11-11-2012

The Italian Medicines Agency (AIFA) said last Friday that the temporary halt on the use of Swiss drug…

AgrippalAsia-PacificEuropeFluadGenericsJanssenJohnson & JohnsonMylan LaboratoriesNorth AmericaNovartisOrtho Tri-Cyclen LoPatentsPharmaceuticalQVA149RegulationReproductiveRespiratory and PulmonaryVaccines

Novartis' flu vaccines suspended in several countries on suspected quality issues

29-10-2012

A number of European Union member states have halted the use, as a precautionary measure, of some anti-influenza…

AgrifluAgrippalEuropeFluadMarkets & MarketingNorth AmericaNovartisPharmaceuticalRegulationVaccines

US FDA agrees to review Sanofi Pasteur's new quadrivalent influenza vaccine

18-10-2012

Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) says it has filed a supplemental Biologics…

Anti-viralsNorth AmericaPharmaceuticalRegulationSanofiSanofi PasteurVaccines

1 to 25 of 39 results

Parexel

Parexel

Back to top